RIKEN is going to hold the "IMPC International Symposium in Tokyo" in WTC Conference Center, Minato City, Tokyo from 10 am on September 28, Friday.

The International Mouse Phenotyping Consortium, IMPC, is an international collaborative research project to discover the relations between human and mammalian genome and phenotypes - physiological or behavioral characters such as blood elements or auditory and visual perception - using mice as a model.

World leading mouse resource organizations are taking charge of certain number of knockout mouse strains for each to produce live mice, phenotype them in line with the protocols agreed in IMPC, and aggregate and publish the data on the standardized forms.

RIKEN BioResource Center (RIKEN BRC) has joined IMPC since its launch in 2011 and taken a leading role in the standardizing protocols as a representative mouse resource center in Asia.

In this symposium, core members of IMPC and key people from the life science research and drug development in Japan are invited to give a speech and have a discussion on how to utilize IMPC phenotyping data and resources for basic life sciences and prevention, diagnosis and treatment of diseases.

Outline

Date & Time

10:00 - 17:00, September 28, 2012

Place

WTC Conference Center (Hamamatsu-cho, Tokyo)
(The room "Fontaine", 38^th floor of the World Trade Center Building)

Target Audience

Anyone interested in life sciences and drug development
(Admission free / Capacity: 200 people)

Language

English

Organizers

RIKEN, The International Mouse Phenotyping Consortium (IMPC)

Program

10:00 - 10:20	Opening Remarks Yuichi Obata (Director of RIKEN BRC) Opening Addresses Kenji Oeda (Executive Director of RIKEN) Tomohiko Arai (MEXT)
10:20 - 12:00	Session I Overview of IMPC 1. Overview Mark Moore (Executive Director, IMPC) 2. KOMP2 Colin Fletcher (National Institute of Health, USA) 3. MPI2 Hiroshi Masuya (RIKEN BRC) 4. Japan Mouse Clinic Shigeharu Wakana (RIKEN BRC)
13:00 - 13:50	Session II The Value for Basic Sciences Monica Justice (Baylor College of Medicine, USA) Toshihiko Shiroishi (National Institute of Genetics)
13:50 - 14:40	Session III The Value for Drug Discovery Tom Weaver (MRC Harwell, UK) Yoichi Nabeshima (Foundation for Biomedical Research and Innovation)
14:40 - 15:00	Break
15:00 - 15:40	Session IV Distribution of Mouse Knockout Resources Prof. Kent Lloyd (UC Davis, USA) Atsushi Yoshiki (RIKEN BRC)
15:40 - 16:50	Session V Panel Discussion "How to Utilize IMPC Phenotyping Data and IKMC Resources"
16:50 - 17:00	Closing Remarks Kazuo Moriwaki (RIKEN BRC)